Abstract
The in vitro proliferation of T cell acute lymphoblastic leukemia (T-ALL) cells in its entirety has not been well delineated because of a lack of an appropriate culture system that mimics the growth pattern in a living body. We applied a NOD/SCID mouse fetal thymus organ culture (FTOC) for leukemic cells from fresh (one case) and frozen (seven cases) bone marrow (BM) samples of children with T-ALL. Cell growth was observed in all seven samples in the culture, reaching a proliferational peak at 4 weeks, and it was calculated that the proliferation potential was 212-to 319-fold. The FTOC-derived T-ALL cells showed similarity to the original cells morphologically and immunophenotypically, still possessed clonalities and were able to regenerate overt leukemia in NOD/SCID mice. These FTOC-derived T-ALL cells differed from ordinary cell lines because they always need FTOC support. Thus, we established a new in vitro culture for T-ALL cells. A comparison of the original and FTOC-derived T-ALL cells revealed that the proportion of cells expressing IL-7R increased in all seven cases. Sorting and re-seeding of FTOC-derived IL-7R+ and IL-7R− cells into secondary FTOC resulted in a predominant generation of IL-7R+ cells from both fractions, while IL-7R− cells proliferated more potently than did IL-7R+ cells, suggesting that a pathway for the conversion of IL-7R− to IL-7R+ exists during the proliferation of T-ALL lymphoblasts. Addition of exogenous IL-7 or neutralization with anti-IL-7 antibody did not influence the growth pattern of T-ALL cells in FTOC. The current study provides a unique assay system for the exploration of the hierarchy within human T-lymphoid leukemic cells, and should facilitate the establishment of novel therapeutic modalities.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
McCulloch EA . Stem cell renewal and determination during clonal expansion in normal and leukemic haemopoiesis Cell Prolif 1993 26: 399–425
Pui CH, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK, Kalwinsky DK, Sandlund JT, Crist WM, Raimondi SC . Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia Blood 1990 75: 174–179
Foon KA, Todd RF III . Immunologic classification of leukemia and lymphoma Blood 1986 68: 1–31
Roper M, Crist WM, Metzgar R, Ragab AH, Smith S, Starling K, Pullen J, Leventhal B, Bartolucci AA, Cooper MD . Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies Blood 1983 61: 830–837
Makrynikola V, Kabral A, Bradstock K . Effects of interleukin 7 on the growth of clonogenic cells in T-cell acute lymphoblastic leukaemia Leuk Res 1991 15: 879–882
Karawajew L, Ruppert V, Wuchter C, Kosser A, Schrappe M, Dorken B, Ludwig WD . Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with Bcl–2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia Blood 2000 96: 297–306
Ito C, Ribeiro RC, Behm FG, Raimondi SC, Pui CH, Campana D . Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells Blood 1998 91: 1001–1007
Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, Dorken B, Ludwig WD . Constitutive expression level of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia Br J Haematol 2000 110: 154–160
Styczynski J, Pieters R, Huismans DR, Schuurhuis GJ, Wysocki M, Veerman AJP . In vitro drug resistance profiles of adult versus childhood acute lymphoblastc leukaemia Br J Haematol 2000 110: 813–818
Smith SD, Morgan R, Link MP, McFall P, Hecht F . Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma Blood 1986 67: 650–656
O'Connor R, Cesano A, Lange B, Finan J, Nowell PC, Clark SC, Raimondi SC, Rovera G, Santoli D . Growth factor requirements of childhood acute T-lymphoblastic leukemia: correlation between presence of chromosomal abnormalities and ability to grow permanently in vitro Blood 1991 77: 1534–1545
Akashi K, Kondo M, Weissman IL . Role of interleukin-7 in T-cell development from hematopoietic stem cells Immunol Rev 1998 165: 13–28
Dibirdik I, Langlie MC, Ledbetter JA, Tuel-Ahlgren L, Obuz V, Waddick KG, Gajl-Peczalska K, Schieven GL, Uckun FM . Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells Blood 1991 78: 564–570
Masuda M, Takanashi M, Motoji T, Oshimi K, Mizoguchi H . Effects of interleukins 1–7 on the proliferation of T-lineage acute lymphoblastic leukemia cells Leuk Res 1991 15: 1091–1096
Ishii T, Nishihara M, Ma F, Ebihara Y, Tsuji K, Asano S, Nakahata T, Maekawa T . Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors J Immunol 1999 163: 3612–3620
Koyanagi Y, Tanaka Y, Kira J, Ito M, Hioki K, Misawa N, Kawano Y, Yamasaki K, Tanaka R, Suzuki Y, Ueyama Y, Terada E, Tanaka T, Miyasaka M, Kobayashi T, Kumasawa Y, Yamanoto N . Primitive human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL immunodeficient mouse strain J Virol 1997 71: 2417–2424
Sui X, Tsuji K, Ebihara Y, Tanaka R, Muraoka K, Yoshida M, Yamada K, Yasukawa K, Taga T, Kishimoto T . Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34+ cells through glycoprotein (gp) 130 signaling Blood 1999 93: 2525–2532
Ma F, Yang FC, Kaneko A, Manabe A, Tanaka R, Asano S, Nakahata T, Tsuji K . Cytokine requirement for the development of T lymphoid lineage potential in clonal lymphohematopoietic progenitors in vitro Br J Haematol 2000 111: 1170–1179
Theodorou I, Bigorgne C, Delfau MH, Lahet C, Cochet G, Vidaud M, Raphael M, Gaulard P, Farcet JP . VJ rearrangements of the TCR gamma locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis J Pathol 1996 178: 303–310
Hecker KH, Roux KH . High and low annealing temperatures increase both specifity and yield in touchdown and stepdown PCR Biotechniques 1996 20: 478–485
Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, Mitsui T, Manabe A, Tanaka R, Kobayashi K, Ito M, Yasukawa K, Nakahata T . Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor J Clin Invest 2000 105: 1013–1021
Ebihara Y, Tsuji K, Lyman SD, Sui X, Yoshida M, Muraoka K, Yamada K, Tanaka R, Nakahata T . Synergistic action of Flt3 and gp130 signalings in human hematopoiesis Blood 1997 90: 4363–4368
Ma F, Wada M, Yoshino H, Ebihara Y, Ishii T, Manabe A, Tanaka R, Maekawa T, Ito M, Mugishima H, Asano S, Nakahata T, Tsuji K . Development of human lymphohematopoietic stem / progenitor cells defined by CD34 and CD81 expressions Blood 2001 97: 3755–3762
Smedt MD, Leclercq G, Vandekerckhove B, Plum J . Human fetal liver cells differentiate into thymocytes in chimeric mouse fetal thymus organ culture Adv Exp Med Biol 1994 355: 27–31
Lange B, Valtieri M, Santoli D, Caracciolo D, Mavilio F, Gemperlein I, Griffin C, Emanuel B, Finan J, Nowell P, Rovera G . Growth factor requirements of childhood acute leukemia: establishment of GM-CSF dependent cell lines Blood 1987 70: 192–199
Smith SD, Morgan R, Gemmell R, Amylon MD, Link MP, Linker C, Hecht BK, Warnke R, Glader BE, Hecht F . Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34th Blood 1988 71: 395–402
Drexler HG, Matsuo Y, MacLeod RAF . Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research Leukemia Res 2000 24: 881–911
Manabe A, Cuostan-Smith E, Behm FG, Raimondi SC, Campana D . Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia Blood 1992 79: 2370–2377
Kondo M, Weissman IL, Akashi K . Identification of clonogenic common lymphoid progenitors in mouse bone marrow Cell 1997 91: 661–672
Page TH, Willcocks JL, Taylor-Fishwick DA, Foxwell BM . Characterization of a novel high affinity human IL-7 receptor. Expression on T cells and association with IL-7 driven proliferation J Immunol 1993 151: 4753–4763
Matsushita K, Arima N, Yamaguchi K, Matsumoto T, Ohtsubo H, Hidaka S, Fujiwara H, Arimura K, Kukita T, Tokito Y, Ozaki A, Tei C . Granulocyte colony-stimulating factor production by adult T-cell leukaemia cells Br J Haematol 2000 111: 208–215
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ma, F., Manabe, A., Wang, D. et al. Growth of human T cell acute lymphoblastic leukemia lymphoblasts in NOD/SCID mouse fetal thymus organ culture. Leukemia 16, 1541–1548 (2002). https://doi.org/10.1038/sj.leu.2402547
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402547